메뉴 건너뛰기




Volumn 10, Issue 6, 2001, Pages 537-547

Troglitazone (Rezulin) and hepatic injury

Author keywords

Hepatic injury; Hepatotoxicity; Oral hypoglycemics; Troglitazone

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALANINE AMINOTRANSFERASE; BILIRUBIN; GLUCOSE; INSULIN; LIVER ENZYME; METFORMIN; ROSIGLITAZONE; SULFONYLUREA; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL; TROGLITAZONE;

EID: 0035698519     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.652     Document Type: Article
Times cited : (51)

References (12)
  • 1
    • 0008028436 scopus 로고    scopus 로고
    • Food and Drug Administration. HHS News. Rezulin to be withdrawn. US Deprt of HHS. [22 March]
    • (2000)
  • 2
    • 0027953703 scopus 로고
    • Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes
    • (1994) Diabetes , vol.43 , pp. 1066-1084
    • Kahn, C.R.1
  • 12
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complications Trial Research Group
    • (1993) N. Engl. J. Med. , vol.329 , pp. 977-986


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.